Latest oncology News | Page 3

Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer
Ending needless chemotherapy for breast cancer
Mid North Coast pilot of innovative booking technology helping cancer patients get
Nambour Hospital $86 million redevelopment on track
Major donation supports research into early-stage cancer detection
Study reveals elevated cancer risk in children with birth defects
Is sex primarily a strategy against transmissible cancer?
Cashen named Institutional Review Board chair
World No Tobacco Day: A call to action to fight its use in any form
Menarini Ricerche at ASCO Annual Meeting 2019 With Three Different Projects in Oncology
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical
New theatre investment improves surgical outcomes
Apollo Proton Cancer Centre
Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership
Ethical concerns of oncology trial-finding apps
Private oncologists reject PM claims of ‘fee hikes’ for cancer patients
Review encourages education on radiation lung injury
First-in-human trial shows promise in treating neuroblastoma
$63 million boost for radiation therapy services in regional Australia
Putting cancer patients first and closing gap on costs
AirXpanders and Radformation Announce Co-Marketing Agreement
BCNA welcomes Labor’s plan to boost metastatic cancer support
Labor’s Medicare boost for cancer care a tremendous step
April edition of Australian Prescriber out now
New global benchmarks confirm Curtin’s world-class research
NSW Labor to deliver $203 million upgrade to Coffs Harbour Hospital
Funding for lifesaving new cancer service in Great Southern
Andrews Hangs Radiation Therapists Out to Dry
Aspirin and similar drug use linked to lower endometrial cancer risk in overweight women
World-first program uncovers errors in biomedical research results
BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants